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Human induced pluripotent stem cells (iPSCs) from a
healthy 86-year-old male were differentiated into
neural stem cells and grafted into adult immunodefi-
cient rats after spinal cord injury. Three months after
C5 lateral hemisections, iPSCs survived and differen-
tiated into neurons and glia and extended tens of
thousands of axons from the lesion site over virtually
the entire length of the rat CNS. These iPSC-derived
axons extended through adult white matter of the
injured spinal cord, frequently penetrating gray mat-
ter and forming synapses with rat neurons. In turn,
host supraspinal motor axons penetrated human
iPSC grafts and formed synapses. These findings
indicate that intrinsic neuronal mechanisms readily
overcome the inhibitory milieu of the adult injured
spinal cord to extend many axons over very long dis-
tances; these capabilities persist even in neurons
reprogrammed from very aged human cells.
INTRODUCTION
Recent findings indicate that multipotent neural progenitor cells
derived from either embryonic spinal cord or embryonic stem
(ES) cells extend abundant numbers of axons over long dis-
tances when implanted into sites of spinal cord injury (SCI) (Lu
et al., 2012b). These cells form functional relays across sites of
complete spinal cord transection to restore conductivity across
a lesion site and improve functional outcomes (Lu et al.,
2012b). Grafts of neural progenitor cells can also remyelinate
spared axons surrounding sites of partial spinal cord injury and
may have neuroprotective properties (Cummings et al., 2005;
Keirstead et al., 2005; Plemel et al., 2011).
These properties of neural stem cells raise the possibility of
developing experimental treatments for spinal cord injury. How-
ever, immunosuppression to allow neural stem cell grafting in
humans with spinal cord injury is potentially hazardous, given
compromised health and high risk of infection in traumatized
patients. Alternative cell sources that may not require immuno-suppression could constitute a major advance. Accordingly,
we explored whether human induced pluripotent stem cells
(iPSCs) exhibit similar properties of engraftment, differentiation,
and axonal outgrowth when driven to a neural stem cell fate.
Human iPSCs were differentiated into neural stem cells and
implanted into immunodeficient rats 2 weeks after C5 lateral
hemisection lesions, a clinically relevant treatment time period.
Three months later, we found an unprecedented degree of
axonal outgrowth: indeed, axons extended nearly the entire
rostral-to-caudal extent of the adult rat nervous system and
formed synapses with rodent neurons, while host axons pene-
trated human iPSC grafts and also formed synapses.
RESULTS
Human iPSCs were derived from a healthy 86-year-old male and
driven toward a neural stem cell (NSC) lineage, as previously
described (Yuan et al., 2011; Israel et al., 2012). Briefly, primary
dermal fibroblasts were transduced with retroviral vectors ex-
pressing OCT4, SOX2, KLF4, and c-MYC, cultured on PA6 cells
in the presence of SMAD inhibitors for induction of neural stem
cells (Yuan et al., 2011), and fluorescence-activated cell sorting
(FACS)-purified using CD184+, CD15+, CD44, and CD271.
Purified neural stem cells were then cultured on polyornithine/
laminin-coated plates with DMEM/F12 supplemented with N2,
B27, and basic fibroblast growth factor. This iPSC-derived
NSC line was extensively characterized in vitro, including immu-
nocytochemistry, genome-wide mRNA expression profiles, and
electrophysiology (Israel et al., 2012). Proliferating NSCs were
transduced with lentiviral vectors expressing GFP (Taylor et al.,
2006). FACS analysis reviewed that more than 99% of NSCs
expressed GFP (Figure S1A available online). In addition,
NSCs, whether transduced with GFP or not, dramatically down-
regulated expression of the conventional pluripotency markers
Tra1-81 and SSEA4 (Figures S1B and S1C) and maintained
expression of NSC-associated markers, including nestin and
Sox2 (Figures S1D and S1E) (Israel et al., 2012). GFP-expressing
NSCs were harvested and embedded in fibrin matrices contain-
ing a growth factor cocktail (see Experimental Procedures; Lu
et al., 2012b) to promote graft survival and retention in the lesion
site. Cells were grafted into C5 spinal cord hemisection lesion
sites (n = 7), 2 weeks after the original spinal cord injury. ControlNeuron 83, 789–796, August 20, 2014 ª2014 Elsevier Inc. 789
Figure 1. Survival, Differentiation, and
Growth of Human iPSC-Derived Neural
Stem Cells in Sites of Spinal Cord Injury
(A) GFP-labeled human iPSC-derived neural stem
cells were grafted into sites of C5 hemisection
spinal cord injury. Horizontal section immunola-
beled for GFP and GFAP indicates that implants
survive well and distribute through the lesion
cavity. Rostral is to left, and caudal is to right. (B)
The majority of cells within the graft immunolabel
for mature neuronal markers NeuN, indicating
neuronal differentiation. (C–E) Very large numbers
of GFP-labeled axons extend caudally into the
host spinal cord (D) white matter and (E) gray
matter (region of NeuN labeling). Insets in (C)
indicate that axons colocalize with Tuj1 but not
neurofilament (NF). (F and G) GFP, MBP, and
NeuN triple labeling of a coronal section three
segments (C8) caudal to the graft shows dense
distribution of human axons predominantly on
right, lesioned side of the spinal cord. (G) Higher
magnification of (F) from lateral white matter
demonstrates remarkably high number of human
axons interspersed in white matter. Scale bar in-
dicates 350 mm in (A), 10 mm in (B), 600 mm in (C),
32 mm in (D) and (E), 250 mm in (F), and 20 mm in (G).
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Extensive Axonal Growth of Human iPSC-Derived NSCssubjects (n = 5) underwent the same lesions and injections of the
fibrin matrix containing the growth factor cocktail lacking neural
stem cells. Subjects underwent weekly functional assessment
and were perfused 3 months postgrafting.
Survival, Differentiation, and Axonal Outgrowth from
Grafted Human iPSC-Derived NSCs
When examined 3 months posttransplantation, grafted human
iPSC-derived NSCs survived and were distributed through
most of the lesion (Figure 1A; Figures S2A–S2G). Grafts in four
of seven animals exhibited a rift near the center of the graft (Fig-
ures S2D–S2G) that contained collagen that effectively segre-
gated the graft into rostral and caudal components (Figures
S2H and S2I), while grafts in the remaining three animals were790 Neuron 83, 789–796, August 20, 2014 ª2014 Elsevier Inc.freeof rifts but exhibited someattenuation
of cell density near the central region of
the graft (Figures S2A–S2C and S2J).
The majority (71.2% ± 3.1%) of grafted
human iPSC-derived NSCs expressed
the mature neuronal marker NeuN (Fig-
ure 1B; Figure S2K). Grafted cells also ex-
pressed the neuronal markers MAP2 and
Tuj1 (Figures S2L and S2M), whereas
expression of the immature neuronal
marker doublecortin (DCX) was rarely
detected by 3 months postgrafting (data
not shown); 17.7%±2.8%of grafted cells
expressed the mature astrocyte marker
GFAP (Figure S2N). We could not detect
expression of themature oligodendrocyte
marker APC in NSC grafts: while NG2-
labeled oligodendrocyte progenitor cellswere present in the graft, they did not colocalize with GFP or hu-
man nuclear antigen (Figures S2O and S2P), suggesting origin
from the host; our iPSC selection conditions favored neuronal
and astrocyte enrichment (see Experimental Procedures). In
addition to general neuronal markers, 4.4% ± 0.9% of grafted
cells expressed choline acetyltransferase (ChAT), characteristic
of spinal motor neurons (Figures S2Q and S2R). No cells within
grafts detectably expressed the serotonergic neuronal marker,
5-HT. Some grafted cells migrated into the host spinal cord
adjoining the lesion site (Figure 1A) and expressed themature as-
trocytic marker GFAP (Figures S2S and S2T). Seven percent of
grafted cells expressed Ki67 (Figures S3A–S3D), suggesting
continued proliferation of a proportion of grafted human cells
3 months postimplantation. No teratomas were observed.
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Extensive Axonal Growth of Human iPSC-Derived NSCsGrafted human iPSC-derived NSCs extended very large
numbers of GFP-expressing immunoreactive axons directly
out of the lesion site and into the host spinal cord (Figures 1C–
1G). The axonal nature of these GFP-expressing projections
from the lesion site was confirmed by GFP colocalization with
Tuj1 (ßIII-tubulin, Figure 1C, inset). Interestingly, despite expres-
sion of mature neuronal markers by cell somata in the graft, few
GFP-expressing graft-derived axons that had grown out of the
graft expressed the mature axonal marker neurofilament (NF)
3 months postgrafting (Figure 1C, inset). The number of GFP-
labeled human axons emerging caudally from the hemilesion
site was quantified in a series of horizontal sections at a point
0.5 mm caudal to the lesion site in the entire right hemicord of
a representative subject: 20,500 axons were identified, a conser-
vative estimate, because bundles of axons that could not be
independently resolvedwere counted as single axons. This num-
ber is 41%higher than the number of axons emerging from grafts
of rat-derived neural progenitor cells per hemicord in our previ-
ous report (Lu et al., 2012b). Indeed, within three spinal seg-
ments of implantation, the density of graft-derived human axons
appeared to qualitatively equal that of rodent host axons in some
regions of white matter (Figure 1G). Notably, human axons grew
in organized, rostrocaudal linear trajectories in host white matter
(Figures 1D, 1F, and 1G). Throughout the course of their white
matter projections, human axons gave off branches that dove
into host gray matter (Figures 1E; Figures S3E–S3H). Human
axons in host gray matter were highly ramified (Figures 1E;
Figures S3E–S3H), similar to patterns of endogenous axonal
branching and termination in host gray matter. Many human
axons terminated in lamina IV to VII (Figure 1F). The density of
human axons extending in rostral and caudal directions from
the implant site qualitatively appeared equal (Figures S3I–S3P).
Long-Distance Growth and Connectivity of Grafted
Human iPSC-Derived NSCs
Human NSC graft-derived axons extended over very long
distances in the host spinal cord, continuing to extend into the
brain and even reaching the olfactory bulb (Figure 2). Indeed,
from the C5 lesion site axons extended through adult host white
matter as far caudally as the distal lumbar spinal cord (Figures
2A–2D) and as far rostrally as the frontal cortex and olfactory
bulb (Figures 2E–2K); human axons essentially extended the
entire length of the adult rat neuraxis. Most rostrally extending
axons grew as a bundle through the ventrolateral spinal cord
and ventral portion of the brainstem (Figure 2E), continuing to
extend rostrally through the region of the hypothalamus (Fig-
ure 2E). The total distance traversed corresponded to more
than 26 spinal segments, greater than 9 cm in length; this ex-
ceeds by 2-fold the distance over which axons emerged from
grafts of rat multipotent neural precursor cells in our previous
study (Lu et al., 2012b). Axon density progressively diminished
as a function of distance from the graft.
Recently, it was reported that grafts of multipotent neural
progenitor cells can spread from an implantation site in approx-
imately half of cases, although teratomas are not observed
(Steward et al., 2014; Tuszynski et al., 2014). After grafting hu-
man iPSCs in the present study, we observed cell spread into
the central canal for up to three segments from the implantationsite in four of seven grafted animals (Figures S3Q–S3T). There
were not, however, ectopic collections or nodules of cells at
more remote segments from the lesion, including the distal spi-
nal cord, brainstem, or brain after examining every sixth section
labeled for GFP throughout the neuraxis. Graft cells that spread
into the central canal extended axons into the immediately
adjoining spinal cord, but these did not extend farther than
0.5–1 mm into host parenchyma. Notably, the extraordinarily
high number of axons extending into host white matter sur-
rounding the lesion site emerged directly from grafts in the
lesion site (Figures 1A and 1C) and not from the modest
numbers of neurons located in ectopic cell nests in the central
canal (which extended axons into the host spinal cord for more
limited distances). Similarly, axons extending into the brainstem
and brain were direct extensions of axons in ventromedial white
matter emerging from grafts placed in the lesion site, as
observed in Figure 2E; these axons did not arise from the
modest numbers of neurons located in ectopic cell nests in
the central canal. Tracing of individual axons from the olfactory
bulb and lumbar spinal cord to the midcervical spinal cord graft
would be required to state with certainty that axons visualized
as far rostrally as the olfactory bulb and as far caudally as the
lumbar spinal cord arose from the graft, rather than these iso-
lated cell nests. However, the preponderance of evidence sug-
gests that these long-growing axons originated from the graft in
the lesion site: axons emerging from the graft numbered in the
tens of thousands and could be visualized extending directly
into the brainstem, whereas (1) the number of cells in ectopic
nests was far lower, (2) cell nests were present only up to three
segments from the lesion site, and (3) axons arising from these
nests extended few axons in comparison to grafts in the lesion
site.
Previously, we reported that grafted rat NSC-derived axons
were frequently myelinated by host rat oligodendrocytes in spi-
nal cord white matter 7 weeks postgrafting (Lu et al., 2012b).
Three months postgrafting an extremely high density of human
iPSC-derived axons extended through adult white matter
(Figures 1C, 1D, 1F, 1G, 2A, 2B, 2E, 2H, 3A, and 3B; Figures
S3E–S3P). These extending human axons frequently directly
contacted host myelin membranes (Figures 3A–3C), suggesting
that graft-derived axons are not inhibited by adult myelin
(Schwab et al., 2005). However, graft-derived human axons
were not detectably myelinated by rat host oligodendrocytes
(Figures 3A–3C).
GFP-labeled human axons formed bouton-like terminals in
host rat gray matter (Figure 3D). These structures colocalized
with synaptophysin and were present at all levels of the rat spinal
cord in close apposition to host neurons and dendrites, including
choline acetyltransferase-expressing host spinal motor neurons
(Figure 3E). Human-specific synaptophysin labeling was de-
tected at human axon terminals in host spinal cord gray matter
and was distributed predominantly in laminae VI-VII (Figure 3F;
Figures S4A, S4B, S4D, and S4E). Human axon terminals
expressing human-specific synaptophysin were frequently in
direct contact with host neuronal dendrites labeled with MAP-2
(Figure 3F). Given the availability of a human-specific synapto-
physin label (hSyn, Chemicon), we were able to quantify the
relative contribution of human synaptophysin to totalNeuron 83, 789–796, August 20, 2014 ª2014 Elsevier Inc. 791
Figure 2. Long-Distance Growth of iPSC-
Derived NSCs
(A–D) Light-level GFP immunolabeling of human
iPSC-derived axons in coronal sections shows very
large numbers of axons extending into caudal host
spinal cord. Insets in each panel show the sampled
region fromwhich higher-magnification views were
obtained: (A) C8, (B) T6, (C) T12, and (D) L4. (E)
Fluorescent GFP-labeled human iPSC-derived
axons extend rostrally into brain in a sagittal section
at a low magnification. (F–H) Higher-magnification
views from the boxed areas in (E) show that GFP-
labeled human axons extend into (F) midbrain and
(G) gracile (Gr) and solitary (Sol) nuclei; (H) very
large numbers of axons enter the medulla. NeuN
labels host brain neurons. (I–K) Individual GFP-
labeled human axons are present in (I) cortex, (J)
olfactory bulb, and (K) cerebellum. Insets indicate
region of sampling. Scale bar indicates 20 mm in
(A)–(C), 60 mm in (D), 1.7mm in (E), 110 mm in (F) and
(H), 180 mm in (G), and 100 mm in (I)–(K).
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Extensive Axonal Growth of Human iPSC-Derived NSCssynaptophysin at a location three spinal segments caudal to the
graft, at the C8 level: human synaptophysin accounted for 9% of
total synaptophysin at this level (Figures S4A–S4F). In addition, a
modest number of human axon terminals expressed vesicular
glutamate transporter 1 (vGlut1), suggesting the presence of
glutamatergic terminals (Figure 3G), whereas expression of
GABAergic markers was not detected. However, the overall
expression of transmitter-associated markers was relatively
modest, possibly reflecting the still-developing nature of many792 Neuron 83, 789–796, August 20, 2014 ª2014 Elsevier Inc.human axons at this stage. Immunoelec-
tron microscopy confirmed the presence
of synaptic structures forming between
GFP-labeled, graft-derived human axons
and host dendrites (Figure 3H).
Long-Distance Growth and
Connectivity of Human Axons Is Not
a Result of Cell Fusion
A priori it is extremely unlikely that the
human axons observed in this study
were a result of fusion with host rat spinal
cord neurons, given (1) the very high
density of GFP-expressing axons, (2) their
presence in axonal tracts originating from
the brain (where fusion could not have
occurred), and (3) their projection to
ectopic locations (such as the olfactory
bulb). To confirm the absence of fusion,
we performed an additional study. Human
iPSC-derived NSCs were transduced
with lentiviral vectors to express red fluo-
rescent protein (RFP) and were grafted
into C5 hemisection lesion sites in trans-
genic GFP-expressing mice (n = 4). The
recipient mice were immunodeficient (Ni-
clou et al., 2008).When examined 1month
after grafting, numerous graft-derivedaxons emerged from the lesion site; cells or axons double
labeled for RFP (human) and GFP (rats) were never detected
(Figures 4A and 4B).
Host Axonal Growth into Grafted Human
iPSC-Derived NSCs
We examined whether host axons also grew into human iPSC-
derived NSC grafts. Host serotonergic axons, which exert
important roles in modulating motor function (Ribotta et al.,
Figure 3. Association of Human Axons with
Host Myelin and Connectivity with Host
(A and B) GFP and MBP double labeling indicate
close association of human axons with host myelin
in white matter. (A) Horizontal and (B) coronal
section (C8). Myelination of human axons is not
evident. (C) Electron microscopy confirms that
extending iPSC-derived graft (g) axons contact
host myelin sheaths. (D) GFP-expressing human
axon terminals are closely associated withMAP-2-
expressing host neurons and dendrites caudal to
the lesion site. (E) A z stack image triple labeled for
GFP, synaptophysin (Syn), and ChAT, indicating
coassociation of graft-derived human axon termi-
nals with a synaptic marker in direct association
with host motor neurons. (F) A z stack image triple
labeled for GFP, human-specific synaptophysin
(hSyn), and MAP2, showing graft-derived human
axon terminals with a synaptic marker in direct
association with host dendrites. (G) Double label-
ing for GFP, vesicular glutamate transporter 1
(vGlut1) showing a graft-derived human axon
terminal coexpression of vGlut1. (H) Electron
microscopy confirms that DAB-labeled, GFP-ex-
pressing human axon terminals form synapses
(arrowhead) with host dendrites (see inset). Scale
bar indicates 4 mm in (A) and (D), 2 mm in (B), (E),
and (G), 500 nm in (C), 1.8 mm in (F), and 200 nm
in (H).
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NSC grafts and expressed the presynaptic terminal marker
synaptophysin (Figures 4C–4F). Their growth into iPSC grafts
significantly exceeded growth into the lesion cavity in control
animals by 6-fold (p < 0.001; Figure 4G). The reticulospinal
motor projection to the spinal cord was anterogradely labeled
by injecting biotinylated dextran amine (BDA) into the pontine
paragigantocellular reticular nucleus (Lu et al., 2012a). Reticulo-
spinal motor axons also penetrated human iPSC-derived NSC
grafts (Figures S4G–S4I). Thus, reciprocal connections from
host-to-graft (Figure 4; Figures S4G–S4I) and graft-to-host (Fig-
ure 3) were present.
The presence of both host-to-graft and graft-to-host synaptic
structures generated a potential mechanism for creating relaysNeuron 83, 789–79across lesions that could support func-
tional recovery (Lu et al., 2012b). How-
ever, as noted earlier, collagenous rifts
were present within the centers of most
grafts, and axons did not cross these rifts
(Figures S2D–S2I); this could lead to
disconnection of proximal and distal graft
segments. In addition, among grafts lack-
ing clear midline rifts, there were regions
of cell density attenuation in the graft
core (Figures 1A; Figures S2A–S2C and
S2J) that also reduced potential sub-
strates for neural relay formation. When
behavioral outcomes were assessed on
three tasks sensitive to forelimb function
(grid-walking, grooming, and verticalexploration), functional recovery was not observed (Figures
S4J and S4L).
DISCUSSION
We recently reported that neural stem cells extend axons over
very long distances when grafted to the injured spinal cord (Lu
et al., 2012b), despite the inhibitory milieu of the adult CNS.
We now report yet more extensive growth of neural stem cells
derived from human iPSCs: human axons extend in both greater
numbers and over virtually the entire length of the rat CNS.
Indeed, in some regions of the injured spinal cord, the number
of human axons appears nearly equal to rat axons (Figures 3A
and 3B). Human axons form synapses onto rodent neurons,6, August 20, 2014 ª2014 Elsevier Inc. 793
Figure 4. Lack of Cell Fusion, Host Axonal
Ingrowth into Grafts
(A) Triple labeling for RFP, GFP, and NeuN reveals
survival and neurite extension fromRFP-expressing
human iPSC-derived NSCs into GFP transgenic
adult mice with C5 spinal cord lesions. (B) Higher-
magnification view from host white matter 2 mm
caudal to the graft shows that RFP-labeled human
axons do not colocalize with GFP-expressing host
white matter processes. Individual RFP axons are
distinct from host GFP axons in inset. (C) Host (h)
raphespinal axons penetrate a control lesion (Les)
site (injected at the time of grafting with a fibrin/
thrombin matrix, but no cells); dashed lines indicate
host/lesion interface. (D) Host raphespinal axons
penetrate an iPSC graft (g) in the lesion site; the
boxed region is shown in (E). (F) Serotonergic axons
penetrating grafts in the lesion site express the
presynaptic protein synaptophysin. (G) Quantifica-
tion shows a 6-fold increase in penetration of host
serotonergic axons into the lesion site compared to
controls, p < 0.001. Data are represented as
mean ± SEM. Scale bar indicates 100 mm in (A),
22 mm in (B), 120 mm in (C) and (D), 10 mm in (E), and
5 mm in (F).
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aptic proteins. Notably, this degree of axonal extension occurs
from cells of an 86-year-old human, indicating that age does
not appear to be a barrier to the expression of highly plastic
properties of neural stem cells grafted into models of central
injury. These findings provide further support that intrinsic
neuronal growth mechanisms overcome the inhibitory milieu
of the injured adult CNS, permitting extensive and very long-
distance axonal growth.
While previous studies grafted iPSC-derived neural stem cells
in models of spinal cord injury, the extensive degree of axonal794 Neuron 83, 789–796, August 20, 2014 ª2014 Elsevier Inc.growth that we detect was not previously
recognized, possibly because reporter
genes or their promoters were weaker
(Tsuji et al., 2010; Nori et al., 2011; Fuji-
moto et al., 2012; Nutt et al., 2013). Our
vectors robustly express enhanced GFP
using a hybrid chick b-actin promoter
(Taylor et al., 2006). Moreover, our grafting
method appears to result in superior graft
survival and filling of the lesion site, which
may support emergence of greater
numbers of axons.
Human axons in this experiment were in
direct physical contact with ratmyelin (Fig-
ure 3C), yet their growth was not inhibited.
It is possible that the lengthened develop-
mental period of human compared to rat
neurons allowed human axons to grow
for longer distances prior to the expression
of cell surface receptors that mediate
axon-glial interactions and myelin-associ-
ated inhibition. Indeed, human axonsemerging from grafts commonly expressed the early axonal
marker Tuj1 but not the mature axonal marker neurofilament,
suggesting that as axons extend outward from the lesion site,
they are still at a developmental stage. The expression of neuro-
filament in the developing human CNS starts as late as gesta-
tional week 25 (>6 months) (Pundir et al., 2012), and it is possible
that axons had not yet reached this stage of relative maturity. A
prolonged developmental period of human neurons could also
account for the lack of detectable myelination of human axons
in the rat spinal cord in this experiment: human axon myelination
might require neuronal maturation or contact/stabilization with a
Neuron
Extensive Axonal Growth of Human iPSC-Derived NSCshost target neuron. Previous reports demonstrate that human ol-
igodendrocytes are capable of myelinating rodent axons (Keirst-
ead et al., 2005; Wang et al., 2013), suggesting that axon-glial
signals governing myelination are conserved across these
species.
Host axons grew into human iPSC-derived neural stem cell
grafts placed in the C5 hemisection lesion site and formed syn-
aptic structures, and human axons grew in both directions
from the lesion site and formed synaptic structures with host
neurons and dendrites. Yet persistent functional improvement
was not detected, in contrast to our previous study grafting rat
or human neural progenitors to sites of spinal cord injury (Lu
et al., 2012b). Numerous mechanisms may account for a lack
of functional benefit in this study, including (1) separation of
the graft into rostral and caudal compartments by a central
collagenous fissure, across which relays did not extend, (2)
continuing maturation of grafted cells, such that too few neurons
were fully mature and functional at the time of behavioral assess-
ment to support recovery, (3) an absence of myelination of
grafted axons (Alto et al., 2009), (4) formation of ectopic projec-
tions that were functionally detrimental, (5) insufficient expres-
sion of neurotransmitters that are compatible with normal circuit
function, or (6) a type I error in which too few animals were stud-
ied to yield significant differences.
Can one conclude from the present study that human iPSC-
derived neurons are inferior to ES-derived or neural progenitor
cells in supporting functional recovery, since we observed signif-
icant functional improvement in our previous study after grafting
multipotent neural precursor cells to sites of T3 complete tran-
section (Lu et al., 2012b), but no functional improvement in the
present study? No. The comparison of behavioral outcomes be-
tween studies is complex. Our previous study (Lu et al., 2012b)
assessed outcomes on hindlimb locomotion, which reflects
whether supraspinal inputs from above the lesion are activating
pattern generators for locomotion that are located entirely below
the lesion; reconstruction of the (preserved) pattern generator is
not necessary, only the activation of this circuitry. In contrast, the
motor endpoints in the current study consist of more complex
use and placement of the forepaw, features that are not driven
by local pattern generators and that probably require more accu-
rate innervation and integration of several supraspinal inputs to
local segmental motor output neurons. Moreover, this lesion
was a hemisection rather than a complete transection, thus
host axon sparing and sprouting may support, or interfere with,
functional improvement (Tuszynski and Steward, 2012). A deter-
mination of relative functional benefits of iPSC-derived neural
stem cells, embryonic-derived neural stem cells, and rodent-
derived neural stem cells requires concurrent study in the
same model system to draw clear conclusions. Moreover, in
the present iPSC, grafts contained collagenous rifts that divided
grafts into rostral and caudal compartments across which axons
did not travel, precluding formation of neuronal relays across the
lesion to restore function. Grafts in our previous study did not
contain large rifts, although smaller rifts were present in some
cases (Lu et al., 2012b). We also observe collagenous rifts
when grafting neural stem cells into animals with chronic injuries
(P.L. et al., unpublished data). We are currently attempting to
attenuate or eliminate rifts by degrading collagen in the lesioncavity at the time of neural stem cell grafting. Interestingly, grafts
into closed contusion cavities do not consistently form rifts (P.L.
et al., unpublished data), suggesting that cells from the leptome-
ninges in open lesion cavities form these scars. Spinal cord
contusion is the most common mechanism of human injury,
and rift formation may therefore not be a limiting factor in consid-
ering future human translation.
iPSC-derived cells offer the possibility of avoiding immuno-
suppressant drugs that are problematic in an already severely
injured and vulnerable human population. One human iPSC
line was the subject of the present study, and additional lines
need to be tested to determine the extent to which heterogene-
ity in donor source and methods of cell preparation (Toivonen
et al., 2013) may influence graft survival, axon outgrowth, and
functional connectivity. In addition, specific iPSC lines have
differing teratogenic properties (Tsuji et al., 2010; Nori et al.,
2011; Fujimoto et al., 2012). Yet the present demonstration
that human neural stem cells exhibit the most extensive
outgrowth of axons from a spinal cord lesion site yet reported,
that these properties are observed even when using donor cells
of old age, and that grafting can be performed after clinically
relevant treatment delays, motivates the performance of addi-
tional studies that more fully identify and utilize optimal cell
types for nonhuman studies of neural injury and for potential
future translational trials. Prior to considering clinical trials,
several additional points should be addressed: can extending
axons be guided toward appropriate targets and away from
inappropriate targets? Might axons that project to ectopic tar-
gets result in adverse behavioral consequences? How will grafts
affect sensory and autonomic outcomes? Will projections
arising from grafted neural stem cells, like the naturally devel-
oping nervous system, undergo pruning, as some projections
are strengthened and others eliminated? These and related
studies will determine whether the extensive axonal growth
observed from iPSC-derived neural stem cells can be har-
nessed for therapeutic benefit.
EXPERIMENTAL PROCEDURES
Human iPSCs and NSCs
The generation of human iPSCs and NSCs was described previously (Yuan
et al., 2011; Israel et al., 2012). NSCs were transduced with lentiviral vectors
expressing GFP (Taylor et al., 2006).
In Vivo Studies
Adult female athymic nude rats (n = 14) and adult SCID mice (n = 4) under-
went C5 lateral spinal cord lesions; seven rats received human iPSC-derived
NSC grafts, and five controls received no grafts; all underwent weekly behav-
ioral analysis for 3 months postgrafting. Two additional subjects were grafted
and dedicated to ultrastructural analysis. Four SCID-GFP mice received
RFP-expressing iPSC grafts for study of cell fusion over a 1 month survival
period.
Anatomical Analysis
Spinal cord blocks containing iPSC grafts, the rest of spinal cord, and brain
were sectioned and immunolabeled for GFP and additional cell markers. We
quantified neural cell differentiation, the density of human axons and synapto-
physin. Host axonal growth was identified by 5-HT immunolabeling and BDA
anterograde tracing.
Statistical Methods are noted in Supplemental Experimental Procedures.
Additional details are in Supplemental Experimental Procedures.Neuron 83, 789–796, August 20, 2014 ª2014 Elsevier Inc. 795
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